YI
111, Inc.
NASDAQ · CNHealthcareMedical - Pharmaceuticals
$3.94+8.54%
Price as of Jul 20, 2026
YI growth
111, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- -21.2%
- EBITDA
- —
- EBIT
- —
- EPS
- -22.6%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -3.3%
- EBITDA
- -92.6%
- EBIT
- —
- Net income
- +74.0%
- EPS
- +1.3%
- Free cash flow
- -53.7%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.